GNAI1 and cancer: In this regard, selective activation of the GPR84-Gi pathway with minimal β-arrestin recruitment by Gi-biased GPR84 agonists such as DL-17521 or PSB-1667151 may promote more sustained macrophage phagocytosis of cancer cells compared to 6-OAU.